日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transvitreal endoresection of peripheral exudative hemorrhagic chorioretinopathy: a clinicopathological study

经玻璃体切除术治疗周边渗出性出血性脉络膜视网膜病变:一项临床病理学研究

Kase, Satoru; Shimizu, Ai; Ishida, Susumu

Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists' Visual Estimates

细胞密度估计方法评估:人工智能计数与病理学家视觉估计的比较

Kiyuna, Tomoharu; Cosatto, Eric; Hatanaka, Kanako C; Yokose, Tomoyuki; Tsuta, Koji; Motoi, Noriko; Makita, Keishi; Shimizu, Ai; Shinohara, Toshiya; Suzuki, Akira; Takakuwa, Emi; Takakuwa, Yasunari; Tsuji, Takahiro; Tsujiwaki, Mitsuhiro; Yanai, Mitsuru; Yuzawa, Sayaka; Ogura, Maki; Hatanaka, Yutaka

The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition

日本乳腺癌学会乳腺癌病理诊断临床实践指南(2022版)

Honma, Naoko; Yoshida, Masayuki; Kinowaki, Keiichi; Horii, Rie; Katsurada, Yuka; Murata, Yuya; Shimizu, Ai; Tanabe, Yuko; Yamauchi, Chikako; Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira

MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF

MIG6缺失通过低剂量EGF激活EGFR,使非小细胞肺癌对ALK/ROS1抑制剂产生耐药性。

Nobuyuki Kondo ,Takahiro Utsumi ,Yuki Shimizu ,Ai Takemoto ,Tomoko Oh-Hara ,Ken Uchibori ,Sophia Subat-Motoshi ,Hironori Ninomiya ,Kengo Takeuchi ,Makoto Nishio ,Yasunari Miyazaki ,Ryohei Katayama

Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region

即使在肿瘤区域内,原发肿瘤或转移性腋窝淋巴结中程序性死亡配体1阳性免疫细胞的含量低于1%,也能预测三阴性乳腺癌的预后。

Tomioka, Nobumoto; Hatanaka, Kanako C; Okuyama, Dai; Watanabe, Ken-Ichi; Yamamoto, Mitsugu; Maeda, Hideki; Tachikawa, Hanae; Kuwahara, Sayuri; Shimizu, Ai; Suzuki, Hiroaki; Hatanaka, Yutaka; Takahashi, Masato

Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region

更正:即使在肿瘤区域内,原发肿瘤或转移性腋窝淋巴结中程序性死亡配体1阳性免疫细胞的含量低于1%,它们仍可预测三阴性乳腺癌的预后。

Tomioka, Nobumoto; Hatanaka, Kanako C; Okuyama, Dai; Watanabe, Ken-Ichi; Yamamoto, Mitsugu; Maeda, Hideki; Tachikawa, Hanae; Kuwahara, Sayuri; Shimizu, Ai; Suzuki, Hiroaki; Hatanaka, Yutaka; Takahashi, Masato

Helicobacter pylori eradication treatment for primary gastric diffuse large B-cell lymphoma: A single-center analysis

幽门螺杆菌根除治疗原发性胃弥漫性大B细胞淋巴瘤:单中心分析

Saito, Makoto; Mori, Akio; Kajikawa, Sayaka; Yokoyama, Emi; Kanaya, Minoru; Izumiyama, Koh; Morioka, Masanobu; Kondo, Takeshi; Tanei, Zen-Ichi; Shimizu, Ai

Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative case

生长缓慢的WNT型髓母细胞瘤伴非典型磁共振成像表现:病例报告

Mizushima, Makoto; Okamoto, Michinari; Yamaguchi, Shigeru; Oki, Sogo; Motegi, Hiroaki; Sugiyama, Minako; Manabe, Atsushi; Shimizu, Ai; Nishioka, Kentaro; Hashimoto, Takayuki; Hirato, Junko; Kanemura, Yonehiro; Fujimura, Miki

PHOSPHATE exporter XPR1/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer

磷酸盐输出蛋白 XPR1/SLC53A1 是上皮性卵巢癌致瘤性的必要条件

Yoko Akasu-Nagayoshi, Tomoatsu Hayashi, Ayako Kawabata, Naomi Shimizu, Ai Yamada, Naoko Yokota, Ryuichiro Nakato, Katsuhiko Shirahige, Aikou Okamoto, Tetsu Akiyama

Radical resection for solitary thoracic spinous-process metastasis: a case report and technical note

孤立性胸椎棘突转移瘤根治性切除术:病例报告及技术说明

Ishii, Chikako; Iwata, Akira; Yamada, Katsuhisa; Endo, Tsutomu; Tsujimoto, Takeru; Sudo, Hideki; Shimizu, Ai; Iwasaki, Norimasa; Takahata, Masahiko